Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicines)
Pulmonologist
FACCP, MBBS, Diplomate American Board of Internal Medicine, Diplomat American Board of Pulmonary Medicine, Diplomat American Board of Critical Care Medicine, Diplomat American Board of Sleep Medicine
Pulmonologist
FACCP, MBBS, Diplomate American Board of Internal Medicine, Diplomat American Board of Pulmonary Medicine, Diplomat American Board of Critical Care Medicine, Diplomat American Board of Sleep Medicine
Diabetologist
MBBS, MPH, MHM
Internal Medicine Specialist
MBBS, FCPS
Immunologist
M.B.B.S., Fellow of the American Academy of Allergy Asthma and Immunology (FAAAAI), Diplomat American Board of Internal Medicine, Diplomat American Board of Allergy & Immunology
Immunologist
M.B.B.S., Fellow of the American Academy of Allergy Asthma and Immunology (FAAAAI), Diplomat American Board of Internal Medicine, Diplomat American Board of Allergy & Immunology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, MD (Internal Medicine), FACP, DABIM
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), MRCGP (Medicine), FRCGP
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures